UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 10-Q

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended April 1,December 30, 2023

OR

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF SECURITIES EXCHANGE ACT OF 1934

For the transition period from __________ to __________

Commission File Number 001-35672
graphic

BERRY GLOBAL GROUP, INC.

A Delaware corporation
 101 Oakley Street, Evansville, Indiana, 47710
(812) 424-2904
 IRS employer identification number
20-5234618

Securities registered pursuant to Section 12(b) of the Exchange Act:

Title of each classTrading Symbol(s)Name of each exchange on which registered
Common Stock, $0.01 par value per shareBERYNew York Stock Exchange LLC

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes   No

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).   Yes  No 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company.  See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large Accelerated Filer 
Accelerated Filer
Non-Accelerated Filer
Smaller Reporting Company
Emerging Growth Company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes  ☐ No 

There were 119.2115.9 million shares of common stock outstanding at May 4, 2023.February 7, 2024.





CAUTIONARY STATEMENT CONCERNING FORWARD-LOOKING STATEMENTS

Information included or incorporated by reference in Berry Global Group, Inc.’s filings with the U.S. Securities and Exchange Commission (the “SEC”) and press releases or other public statements contains or may contain forward-looking statements.  This report includes “forward-looking” statements with respect to our financial condition, results of operations and business and our expectations or beliefs concerning future events.  These statements contain words such as “believes,” “expects,” “may,” “will,” “should,” “would,” “could,” “seeks,” “approximately,” “intends,” “plans,” “estimates,” “project,” “outlook,” “anticipates” or “looking forward” or similar expressions that relate to our strategy, plans, intentions, or expectations.  All statements we make relating to our estimated and projected earnings, margins, costs, expenditures, cash flows, growth rates, and financial results or to our expectations regarding future industry trends are forward-looking statements.  In addition, we, through our senior management, from time to time make forward-looking public statements concerning our expected future operations and performance and other developments.  These forward-looking statements are subject to risks and uncertainties that may change at any time, and, therefore, our actual results may differ materially from those that we expected.  All forward-looking statements are made only as of the date hereof, and we undertake no obligation to publicly update or revise any forward-looking statement as a result of new information, future events or otherwise, except as otherwise required by law.

Additionally, we caution readers that the list of important factors discussed in our most recent Form 10-K in the section titled “Risk Factors” and subsequent periodic reports filed with the SEC may not contain all of the material factors that are important to you.  In addition, in light of these risks and uncertainties, the matters referred to in the forward-looking statements contained in this report may not in fact occur.  Accordingly, readers should not place undue reliance on those statements.

2


Berry Global Group, Inc.
Form 10-Q Index
For Quarterly Period Ended April 1,December 30, 2023

Part I.Financial InformationPage No.
 Item 1.Financial Statements: 
  4
  5
  6
  7
  8
 Item 2.1514
 Item 3.2117
 Item 4.2118
Part II.Other Information 
 Item 1.2219
 Item 1A.2219
 Item 2.2219
Item 5.20
 Item 6.2320
 2421


3

Index

Part I. Financial Information

Item 1.Financial Statements

Berry Global Group, Inc.
Consolidated Statements of Income
(Unaudited)
(in millions of dollars, except per share amounts)

 Quarterly Period Ended  Two Quarterly Periods Ended  Quarterly Period Ended 
 April 1, 2023  April 2, 2022  April 1, 2023  April 2, 2022  December 30, 2023  December 31, 2022 
Net sales $3,288  $3,775  $6,348  $7,348  $2,853  $3,060 
Costs and expenses:                        
Cost of goods sold  2,682   3,154   5,224   6,192   2,379   2,542 
Selling, general and administrative  220   207   456   442   235   236 
Amortization of intangibles  60   65   120   133   60   60 
Restructuring and transaction activities  25   8   37   11   22   12 
Operating income  301   341   511   570   157   210 
Other expense  1   6   2   6   12   1 
Interest expense  79   71   150   142   72   71 
Income before income taxes  221   264   359   422   73   138 
Income tax expense  47   59   79   96   14   32 
Net income $174  $205  $280  $326  $59  $106 
                        
Net income per share:                        
Basic $1.44  $1.53  $2.29  $2.42  $0.51  $0.86 
Diluted  1.42   1.50   2.27   2.36   0.50   0.85 







Consolidated Statements of Comprehensive Income
(Unaudited)
(in millions of dollars)

 Quarterly Period Ended  Two Quarterly Periods Ended  Quarterly Period Ended 
 April 1, 2023  April 2, 2022  April 1, 2023  April 2, 2022  December 30, 2023  December 31, 2022 
Net income $174  $205  $280  $326  $59  $106 
Other comprehensive income, net of tax:                        
Currency translation  60   37   201   15   139   141 
Derivative instruments  (31)  71   (32)  100   (77)  (1)
Other comprehensive income  29   108   169   115   62   140 
Comprehensive income $203  $313  $449  $441  $121  $246 

See notes to consolidated financial statements.

4

Index

Berry Global Group, Inc.
Consolidated Balance Sheets
(in millions of dollars)

 April 1, 2023  October 1, 2022  December 30, 2023  September 30, 2023 
 (Unaudited)     (Unaudited)    
Assets            
Current assets:            
Cash and cash equivalents $696  $1,410  $507  $1,203 
Accounts receivable  1,751   1,777   1,497   1,568 
Finished goods  1,128   1,010   1,038   933 
Raw materials and supplies  736   792   651   624 
Prepaid expenses and other current assets  220   175   257   205 
Total current assets  4,531   5,164   3,950   4,533 
Noncurrent assets:                
Property, plant and equipment  4,612   4,342   4,662   4,576 
Goodwill and intangible assets  6,866   6,685   6,758   6,684 
Right-of-use assets  507   521   645   625 
Other assets  97   244   129   169 
Total assets
 $16,613  $16,956  $16,144  $16,587 
                
                
Liabilities and stockholders’ equity                
Current liabilities:                
Accounts payable $1,350  $1,795  $1,131  $1,528 
Accrued employee costs  243   253   243   273 
Other current liabilities  715   783   971   902 
Current portion of long-term debt  12   13   25   10 
Total current liabilities  2,320   2,844   2,370   2,713 
Noncurrent liabilities:                
Long-term debt  9,295   9,242   8,703   8,970 
Deferred income taxes  575   707   492   573 
Employee benefit obligations  162   160   202   193 
Operating lease liabilities  414   429   537   525 
Other long-term liabilities  552   378   512   397 
Total liabilities  13,318   13,760   12,816   13,371 
                
Stockholders’ equity:                
Common stock (119.2 and 124.2 million shares issued, respectively)  1   1 
Common stock (116.0 and 115.5 million shares issued, respectively)  1   1 
Additional paid-in capital  1,214   1,177   1,265   1,231 
Retained earnings  2,314   2,421   2,336   2,320 
Accumulated other comprehensive loss  (234)  (403)  (274)  (336)
Total stockholders’ equity  3,295   3,196   3,328   3,216 
Total liabilities and stockholders’ equity $16,613  $16,956  $16,144  $16,587 

See notes to consolidated financial statements.

5

Index

Berry Global Group, Inc.
Consolidated Statements of Cash Flows
(Unaudited)
(in millions of dollars)

 Two Quarterly Periods Ended  Quarterly Period Ended 
 April 1, 2023  April 2, 2022  December 30, 2023  December 31, 2022 
Cash Flows from Operating Activities:            
Net income 
$
280  $326  
$
59  $106 
Adjustments to reconcile net cash from operating activities:                
Depreciation  279   284   154   139 
Amortization of intangibles  120   133   60   60 
Non-cash interest (income) expense, net  (27)  8   (19)  (13)
Settlement of derivatives  36      19    
Deferred income tax  (51)  (43)  (23)  (33)
Share-based compensation expense  30   28   21   23 
Other non-cash operating activities, net  8   (14)  11   (3)
Changes in working capital  (495)  (714)  (490)  (508)
Changes in other assets and liabilities  (12)  (22)  9   (4)
Net cash from operating activities  168   (14)  (199)  (233)
                
Cash Flows from Investing Activities:                
Additions to property, plant and equipment, net  (385)  (367)  (183)  (211)
Acquisition of a business and other  (88)  3 
Net cash from investing activities  (473)  (364)  (183)  (211)
                
Cash Flows from Financing Activities:                
Proceeds from long-term borrowings  500   244   1,550    
Repayments on long-term borrowings  (583)  (9)  (1,858)  (84)
Proceeds from issuance of common stock  18   22   13   5 
Repurchase of common stock  (333)  (351)  (7)  (166)
Dividends paid  (65)     (36)  (33)
Other, net  11      (4)   
Net cash from financing activities  (452)  (94)  (342)  (278)
Effect of currency translation on cash  43   3   28   29 
Net change in cash and cash equivalents  (714)  (469)  (696)  (693)
Cash and cash equivalents at beginning of period  1,410   1,091   1,203   1,410 
Cash and cash equivalents at end of period $696  $622  $507  $717 

See notes to consolidated financial statements.

6

Index

BerryBerry Global Group, Inc.
Consolidated Statements of Changes in Stockholders’ Equity
(Unaudited)
(in millions of dollars)

 
Quarterly Period Ended
 
Common
Stock
  
Additional
Paid-in Capital
  
Accumulated Other
Comprehensive Loss
  
Retained
Earnings
  Total 
Balance at December 31, 2022 $1  $1,199  $(263) $2,322  $3,259 
Net income           174   174 
Other comprehensive income        29      29 
Share-based compensation     7         7 
Proceeds from issuance of common stock     13         13 
Common stock repurchased and retired     (5)     (150)  (155)
Dividends paid           (32)  (32)
Balance at April 1, 2023 $1  $1,214  $(234) $2,314  $3,295 
                     
Balance at January 1, 2022 $1  $1,170  $(289) $2,412  $3,294 
Net income           205   205 
Other comprehensive income        108      108 
Share-based compensation     7         7 
Proceeds from issuance of common stock     6         6 
Common stock repurchased and retired     (9)     (291)  (300)
Balance at April 2, 2022 $1  $1,174  $(181) $2,326  $3,320 

 
Two Quarterly Periods Ended
 
Common
Stock
  
Additional
Paid-in Capital
  
Accumulated Other
Comprehensive Loss
  
Retained
Earnings
  Total 
Balance at October 1, 2022 $1  $1,177  $(403) $2,421  $3,196 
Net income           280   280 
Other comprehensive income        169      169 
Share-based compensation     30         30 
Proceeds from issuance of common stock     18         18 
Common stock repurchased and retired     (11)     (322)  (333)
Dividends paid           (65)  (65)
Balance at April 1, 2023 $1  $1,214  $(234) $2,314  $3,295 
                     
Balance at October 2, 2021 $1  $1,134  $(296) $2,341  $3,180 
Net income           326   326 
Other comprehensive income        115      115 
Share-based compensation     28         28 
Proceeds from issuance of common stock     22         22 
Common stock repurchased and retired     (10)     (341)  (351)
Balance at April 2, 2022 $1  $1,174  $(181) $2,326  $3,320 

  Common Stock  
Additional
Paid-in Capital
  
Accumulated Other
Comprehensive Loss
  
Retained
Earnings
  Total 
Balance at September 30, 2023 $1  $1,231  $(336) $2,320  $3,216 
Net income           59   59 
Other comprehensive income        62      62 
Share-based compensation     21         21 
Proceeds from issuance of common stock     13         13 
Common stock repurchased and retired           (7)  (7)
Dividends paid           (36)  (36)
Balance at December 30, 2023 $1  $1,265  $(274) $2,336  $3,328 
                     
Balance at October 1, 2022 $1  $1,177  $(403) $2,421  $3,196 
Net income           106   106 
Other comprehensive income        140      140 
Share-based compensation     23         23 
Proceeds from issuance of common stock     5         5 
Common stock repurchased and retired     (6)     (172)  (178)
Dividends paid           (33)  (33)
Balance at December 31, 2022 $1  $1,199  $(263) $2,322  $3,259 

See notes to consolidated financial statements.

7

Index

Berry Global Group, Inc.
Notes to Consolidated Financial Statements
(Unaudited)
(tables in millions of dollars, except per share data)


1.  Basis of Presentation

The accompanying unaudited Condensed Consolidated Financial Statements of Berry Global Group, Inc. (“the Company,” “we,” or “Berry”) have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) pursuant to the rules and regulations of the Securities and Exchange Commission (the "SEC") for interim reporting.  Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statementsstatements.  In preparing financial statements in conformity with GAAP, we must make estimates and assumptions that affect the reported amounts and disclosures at the date of the financial statements and during the reporting period.  Actual results could differ from those estimates.  In the opinion of management, all adjustments (consisting of normal recurring adjustments) considered necessary for a fair presentation have been included, and all subsequent events up to the time of the filing have been evaluated.  For further information, refer to the Company’s most recent Form 10-K filed with the SEC.

In fiscal 2023, the Company announced that it initiated a formal process to evaluate strategic alternatives for its Health, Hygiene and Specialties segment and has determined the segment does not meet the criteria of Held for Sale as of December 30, 2023.


2.  Critical Accounting Policies and Recent Accounting Pronouncements

There have been no material changes in critical accounting policies from those described in our most recent Form 10-K.

Reference Rate Reform

In 2020, the FASB issued ASU 2020-04, Reference Rate Reform - Facilitation of the Effects of Reference Rate Reform on Financial Reporting (Topic 848).  This standard provides temporary optional expedients and exceptions to the GAAP guidance on contract modifications and hedge accounting to ease the financial reporting burdens of the expected market transition from LIBOR and other interbank offered rates to alternative reference rates, such as SOFR.  In 2022, the FASB issued ASU 2022-06, which deferred the sunset date of Topic 848 to December 31, 2024.  The Company is evaluating timing of adoption, but does not expect a material change to our consolidated financial statements or disclosures. 

3.  Revenue and Accounts Receivable


Our revenues are primarily derived from the sale of non-woven, flexible and rigid products to customers.products.  Revenue is recognized when performance obligations are satisfied, in an amount reflecting the consideration to which the Company expects to be entitled.  We consider the promise to transfer products to be our sole performance obligation.  If the consideration agreed to in a contract includes a variable amount, we estimate the amount of considerationconsideration we expect to be entitled to in exchange for transferring the promised goods to the customer using the most likely amount method.  Our main sourcesources of variable consideration isare customer rebates.  There are no material instances where variable consideration is constrained and not recorded at the initial time of sale.  Generally, our revenue is recognized at a point in time for standard promised goods at the time of shipment, when title and risk of loss pass to the customer.  The accrual for customer rebates was $95$113 million and $103$106 million at April 1,December 30, 2023 and October 1, 2022,September 30, 2023, respectively, and is included in Other current liabilities on the Consolidated Balance Sheets.  The Company disaggregates revenue based on reportable business segment, geography, and significant product line.  Refer to Note 10.8. Segment and Geographic Data for further information.


Accounts receivable are presented net of allowance for credit losses of $18 million and $18$19 million at April 1,December 30, 2023 and October 1, 2022, respectively.September 30, 2023.  The Company records its current expected credit losses based on a variety of factors including historical loss experience and current customer financial condition.  The changes to our current expected credit losses, write-off activity, and recoveries were not material for any of the periods presented.


The Company has entered into various factoring agreements, including customer-based supply chain financing programs, to sell certain receivables to third-party financial institutions.  Agreements which result in true sales of the transferred receivables, which occur when receivables are transferred without recourse to the Company, are reflected as a reduction of accounts receivabletrade receivables, net on the consolidated balance sheets and the proceeds are included in the cash flows from operating activities in the consolidated statements of cash flows.  The fees associated with the transfer of receivables for all programs were not material for any of the periods presented.

8

4.  Acquisition3.  Restructuring and Transaction Activities

Pro-Western Plastics

In Marchfiscal 2023, the Company acquired Pro-Western Plastics Ltd. (“Pro-Western”), a leading plastics injection molding company, for a purchase priceinitiated cost savings initiatives including plant rationalization in all four segments as part of $88 million.  The acquired business will be operated within the Consumer Packaging North America segment.  To finance the purchase, the Company used existing liquidity.  The acquisition has been accounted for under the purchase method of accounting and accordingly, the purchase price has been allocated to the identifiable assets and liabilities based on preliminary values at the acquisition date.2023 restructuring plan.  The Company has recognized $35 millionexpects total cash and non-cash expense of goodwill on this transaction primarily as a result of expected cost synergies and expects goodwillthe plan to be deductible for tax purposes.

5.  Restructuring and Transaction Activitiesapproximately $200 million, with the operations savings intended to counter general economic softness.  All initiatives are expected to be fully implemented by the end of fiscal 2025.

The table below includes the significant components of ourthe restructuring and transaction activities, by reporting segment:

 Quarterly Period Ended  Two Quarterly Periods Ended  Quarterly Period Ended  Restructuring Plan 
 April 1, 2023  April 2, 2022  April 1, 2023  April 2, 2022  December 30, 2023  December 31, 2022  Life to Date 
Consumer Packaging International $12  $5  $15  $7  $3  $3  $53 
Consumer Packaging North America  7   2   8   3   4   1   27 
Health, Hygiene & Specialties  5      8   (1)  13   3   35 
Engineered Materials  1   1   6   2 
Flexibles  2   5   9 
Consolidated $25  $8  $37  $11  $22  $12  $124 
8




The table below sets forth the activity with respect to the restructuring and transaction activities accrual at April 1,December 30, 2023:

 Restructuring       
  
Employee
Severance
and Benefits
  
Facility
Exit Costs
  
Non-cash
Impairment
Charges
  
Transaction
Activities
  Total 
Balance as of October 1, 2022 $2  $3  $  $  $5 
Charges  16   8   4   9   37 
Non-cash items        (4)     (4)
Cash  (5)  (9)     (9)  (23)
Balance as of April 1, 2023 $13  $2  $  $  $15 
 Restructuring       
  
Employee Severance
and Benefits
  
Facility
Exit Costs
  
Transaction
Activities
  Total 
Balance at September 30, 2023 $10  $1  $  $11 
Charges  9   4   9   22 
Cash payments  (6)  (5)  (9)  (20)
Balance at December 30, 2023 $13  $  $  $13 

6.4.  Leases

The Company leases certain manufacturing facilities, warehouses, office space, manufacturing equipment, office equipment, and automobiles.

Supplemental lease information is as follows:

LeasesClassification April 1, 2023  October 1, 2022 Classification December 30, 2023  September 30, 2023 
Operating leases:              
Operating lease right-of-use assets
Right-of-use assets
 $507  $521 
Right-of-use asset
 $645  $625 
Current operating lease liabilities
Other current liabilities
  109   108 
Other current liabilities
  125   116 
Noncurrent operating lease liabilities
Operating lease liability
  414   429 
Operating lease liability
  537   525 
Finance leases:                  
Finance lease right-of-use assets
Property, plant, and equipment, net
 $34  $38 
Property, plant, and equipment, net
 $32  $32 
Current finance lease liability
Current portion of long-term debt
  9   9 
Current finance lease liabilities
Current portion of long-term debt
  8   9 
Noncurrent finance lease liabilities
Long-term debt, less current portion
  21   24 
Long-term debt, less current portion
  19   19 


9

7.5.  Long-Term Debt

Long-term debt consists of the following:

FacilityMaturity Date April 1, 2023  October 1, 2022 Maturity Date December 30, 2023  September 30, 2023 
Term loan (a)
July 2026 $1,240   3,090 
Term loan (a)
July 2026 $3,390   3,440 July 2029  1,546    
Revolving line of creditMay 2024      June 2028      
0.95% First Priority Senior Secured Notes (b)
February 2024  279   800 February 2024  279   279 
1.00% First Priority Senior Secured Notes (c)
July 2025  761   686 July 2025  773   741 
1.57% First Priority Senior Secured Notes
January 2026  1,525   1,525 January 2026  1,525   1,525 
4.875% First Priority Senior Secured Notes
July 2026  1,250   1,250 July 2026  1,250   1,250 
1.65% First Priority Senior Secured Notes
January 2027  400   400 January 2027  400   400 
1.50% First Priority Senior Secured Notes (c)
July 2027  408   367 July 2027  415   397 
5.50% First Priority Senior Secured Notes
April 2028  500    April 2028  500   500 
4.50% Second Priority Senior Secured Notes
February 2026  291   298 February 2026  291   291 
5.625% Second Priority Senior Secured Notes
July 2027  500   500 July 2027  500   500 
Debt discounts and deferred fees   (42)  (60)   (31)  (34)
Finance leases and otherVarious  45   49 Various  40   41 
Total long-term debt   9,307   9,255    8,728   8,980 
Current portion of long-term debt   (12)  (13)   (25)  (10)
Long-term debt, less current portion  $9,295   9,242   $8,703   8,970 
(a)Effectively 80%98% fixed interest rate with interest rate swaps (see Note 8)6).
(b)Indicates debt which has been classified as long-term debt in accordance with the Company's ability and intention to refinance such obligations on a long-term basis. As of  February 2024, the Company will pay these Notes in full (see Note 12).
(c)Euro denominated

During the quarter ended April 1,December 30, 2023, the Company issued $500extended the maturity date of $1,550 million aggregate principal amount of 5.50% first priority senior secured notes due 2028. The proceeds were usedits outstanding term loans to repurchase a portion of the Company’s 0.95% first priority senior secured notes due 2024.July 2029.
9



Debt discounts and deferred financing fees are presented net of Long-term debt, less the current portion on the Consolidated Balance Sheets and are amortized to Interest expense, net on the Consolidated Statements of Income through maturity. 


8.6.  Financial Instruments and Fair Value Measurements

In the normal course of business, the Company is exposed to certain risks arising from business operations and economic factors.  The Company may use derivative financial instruments to help manage market risk and reduce the exposure to fluctuations in interest rates and foreign currencies.  These financial instruments are not used for trading or other speculative purposes.

Cross-Currency Swaps

The Company is party to certain cross-currency swaps to hedge a portion of our foreign currency risk. The swap agreements mature June 2024 (€1,625 million) and July 2027 (£700 million). In addition to the cross-currency swaps, we hedge a portion of our foreign currency risk by designating foreign currency denominated long-term debt as net investment hedges of certain foreign operations. As of April 1,December 30, 2023, we had outstanding long-term debt of €785€379 million that was designated as a hedge of our net investment in certain euro-denominated foreign subsidiaries. When valuing cross-currency swaps the Company utilizes Level 2 inputs (substantially observable).

Interest Rate Swaps

The primary purpose of the Company’s interest rate swap activities is to manage interest expense variability associated with our outstanding variable rate term loan debt. When valuing interest rate swaps the Company utilizes Level 2 inputs (substantially observable).

During fiscal 2023,2024, the Company elected to cash settle two existing interest rate swaps and received net proceeds of $36$19 million.  The offset is included in Accumulated other comprehensive loss and is being amortized to Interest expense through the term of the original swaps.  Following the settlement, the Company entered into a $450 million and a $500 million interest rate swaps with matching notional amountsswap transaction with expiration in June 2026.2029.

10

As of April 1,December 30, 2023, the Company effectively had (i) a $400 million interest rate swap transaction that swaps a one-month variableSOFR contract for a fixed annual rate of 4.451%, with an expiration in June 2026, (ii) an $884 million interest rate swap transaction that swaps a one-month variable SOFR contract for a fixed annual rate of 4.451% with an expiration in June 2026, (iii) a $500 million interest rate swap transaction that swaps a one-month variable SOFR contract for a fixed annual rate of 3.602%, with an expiration in June 2026 (see Note. 12), (iv) a $450 million interest rate swap transaction that swaps a one-month variable LIBORSOFR contract for a fixed annual rate of 4.128%4.553%, (ii) a $400 million interest rate swap transaction that swaps a one-month variable LIBOR contract for a fixed annual rate of 4.522%, (iii) a $473 million interest rate swap transaction that swaps a one-month variable LIBOR contract for a fixed annual rate of 3.961%, (iv)with an $884 million interest rate swap transaction that swaps a one-month variable LIBOR contract for a fixed annual rate of 4.522%,expiration in June 2029, and (v) a $500 million interest rate swap transaction that swaps a one-month variable LIBORSOFR contract for a fixed annual rate of 3.672%. The Company's interest rate swap transactions all expire4.648%, with an expiration in June 2026.2029.

The Company records the fair value positions of all derivative financial instruments on a net basis by counterparty for which a master netting arrangement is utilized. Balances on a gross basis are as follows:

Derivative InstrumentsHedge DesignationBalance Sheet Location April 1, 2023  October 1, 2022 Hedge DesignationBalance Sheet Location December 30, 2023  September 30, 2023 
Cross-currency swapsDesignatedOther assets $  $147 DesignatedOther current liabilities  142   66 
Cross-currency swapsDesignatedOther long-term liabilities  125    DesignatedOther long-term liabilities  68   19 
Interest rate swapsDesignatedOther assets  1   11 DesignatedOther assets  3   36 
Interest rate swapsDesignatedOther long-term liabilities  39   3 DesignatedOther long-term liabilities  72    
Interest rate swapsNot designatedOther long-term liabilities  113   117 Not designatedOther assets     8 
Interest rate swapsNot designatedOther long-term liabilities  88   104 

The effect of the Company’s derivative instruments, including the amortization of previously settled swaps, on the Consolidated Statements of Income is as follows:

 Quarterly Period Ended  Two Quarterly Periods Ended  Quarterly Period Ended 
Derivative Instruments Statements of Income Location April 1, 2023  April 2, 2022  April 1, 2023  April 2, 2022 Statements of Income Location December 30, 2023  December 31, 2022 
Cross-currency swaps
Interest expense
 $(10) $(4) $(21) $(7)
Interest expense
 $(10) $(11)
Interest rate swaps
Interest expense
  (11)  12   (17)  24 
Interest expense
  (21)  (6)
10



Non-recurring Fair Value Measurements

The Company has certain assets that are measured at fair value on a non-recurring basis when impairment indicators are present or when the Company completes an acquisition.  The Company adjusts certain long-lived assets to fair value only when the carrying values exceed the fair values.  The categorization of the framework used to value the assets is considered Level 3, due to the subjective nature of the unobservable inputs used to determine the fair value.  These assets that are subject to our annual impairment analysis primarily include our definite lived and indefinite lived intangible assets, including Goodwill and our property, plant and equipment.  The Company reviews Goodwill and other indefinite lived assets for impairment as of the first day of the fourth fiscal quarter each year and more frequently if impairment indicators exist.  The Company determined Goodwill and other indefinite lived assets were not impaired in our annual fiscal 20222023 assessment.  No impairment indicators were identified in the current quarter.

Included in the following tabletables are the major categories of assets measured at fair value on a non-recurring basis as of April 1, 2023 and October 1, 2022,their current carrying values, along with the impairment loss recognized on the fair value measurement duringfor the period:period then ended:

 As of April 1, 2023  December 30, 2023 
 Level 1  Level 2  Level 3  Total  Impairment  Level 1  Level 2  Level 3  Total  Impairment 
Indefinite-lived trademarks $  $  $248  $248  $  $  $  $248  $248  $ 
Goodwill        5,032   5,032            5,086   5,086    
Definite lived intangible assets        1,586   1,586            1,424   1,424    
Property, plant, and equipment        4,612   4,612   4         4,662   4,662    
Total $  $  $11,478  $11,478  $4  $  $  $11,420  $11,420  $ 

 As of October 1, 2022  September 30, 2023 
 Level 1  Level 2  Level 3  Total  Impairment  Level 1  Level 2  Level 3  Total  Impairment 
Indefinite-lived trademarks $  $  $247  $247  $  $  $  $248  $248  $ 
Goodwill        4,832   4,832            4,981   4,981    
Definite lived intangible assets        1,606   1,606            1,455   1,455    
Property, plant, and equipment        4,342   4,342            4,576   4,576   8 
Total $  $  $11,027  $11,027  $  $  $  $11,260  $11,260  $8 

11

The Company’s financial instruments consist primarily of cash and cash equivalents, long-term debt, interest rate and cross-currency swap agreements, and finance lease obligations.  The book value of our marketable long-term indebtedness exceeded fair value by $336$221 million as of April 1, 2023.December 30, 2023.  The Company’s long-term debt fair values were determined using Level 2 inputs (substantially observable).

9.7.  Income Taxes

On a year-to-dateIn comparison to the statutory rate, the higherlower effective tax rate for the quarter was negativelypositively impacted by state taxes and global intangible low-taxed income provisions, partially offset by other discrete items.share-based stock compensation.

10.8.  Segment and Geographic Data

The Company’s operations are organized into four reporting segments: Consumer Packaging International, Consumer Packaging North America, Health, Hygiene & Specialties, and Flexibles, formerly known as Engineered Materials.  The structure is designed to align us with our customers, provide optimalimproved service, and drive future growth and to facilitate synergies realization.in a cost efficient manner.
11



Selected information by reportable segment is presented in the following tables:

 Quarterly Period Ended  Two Quarterly Periods Ended  Quarterly Period Ended 
 April 1, 2023  April 2, 2022  April 1, 2023  April 2, 2022  December 30, 2023  December 31, 2022 
Net sales:                  
Consumer Packaging International $1,059  $1,139  $1,995  $2,195  $917  $936 
Consumer Packaging North America  774   880   1,537   1,732   699   764 
Health, Hygiene & Specialties  677   822   1,340   1,640   603   663 
Engineered Materials  778   934   1,476   1,781 
Flexibles  634   697 
Total net sales $3,288  $3,775  $6,348  $7,348  $2,853  $3,060 
Operating income:                
Operating income (loss):        
Consumer Packaging International $75  $97  $121  $166  $31  $47 
Consumer Packaging North America  93   85   164   131   63   71 
Health, Hygiene & Specialties  34   69   68   131   (3)  34 
Engineered Materials  99   90   158   142 
Flexibles  66   58 
Total operating income $301  $341  $511  $570  $157  $210 
Depreciation and amortization:                        
Consumer Packaging International $77  $82  $151  $164  $81  $74 
Consumer Packaging North America  54   53   105   107   57   51 
Health, Hygiene & Specialties  44   44   88   89   46   44 
Engineered Materials  25   27   55   57 
Flexibles  30   30 
Total depreciation and amortization $200  $206  $399  $417  $214  $199 

Selected information by geographical region is presented in the following tables:

 Quarterly Period Ended  Two Quarterly Periods Ended  Quarterly Period Ended 
 April 1, 2023  April 2, 2022  April 1, 2023  April 2, 2022  December 30, 2023  December 31, 2022 
Net sales:                  
United States and Canada $1,751  $1,996  $3,447  $3,948  $1,560  $1,695 
Europe  1,237   1,399   2,286   2,616   1,011   1,050 
Rest of world  300   380   615   784   282   315 
Total net sales $3,288  $3,775  $6,348  $7,348  $2,853  $3,060 

12

11.9.  Contingencies and Commitments

The Company is party to various legal proceedings involving routine claims which are incidental to its business.  Although the Company’s legal and financial liability with respect to such proceedings cannot be estimated with certainty, we believe that any ultimate liability would not be material to our financial position, results of operations or cash flows.

The Company has various purchase commitments for raw materials, supplies, and property and equipment incidental to the ordinary conduct of business.


12.10.  Basic and Diluted Earnings Per Share

Basic net income or earnings per share ("EPS") is calculated by dividing the net income attributable to common stockholders by the weighted-average number of common shares outstanding during the period, without consideration for common stock equivalents.

Diluted EPS includes the effects of options and restricted stock units, if dilutive.
12



The following tables provide a reconciliation of the numerator and denominator of the basic and diluted EPS calculations:

 Quarterly Period Ended  Two Quarterly Periods Ended  Quarterly Period Ended 
(in millions, except per share amounts) April 1, 2023  April 2, 2022  April 1, 2023  April 2, 2022  December 30, 2023  December 31, 2022 
Numerator                  
Consolidated net income $174  $205  $280  $326  $59  $106 
Denominator                        
Weighted average common shares outstanding - basic  120.7   133.8   122.2   134.6   115.6   123.7 
Dilutive shares  1.8   3.1   1.1   3.4   2.7   1.5 
Weighted average common and common equivalent shares outstanding - diluted  122.5   136.9   123.3   138.0   118.3   125.2 
                        
Per common share earnings                        
Basic $1.44  $1.53  $2.29  $2.42  $0.51  $0.86 
Diluted $1.42  $1.50  $2.27  $2.36  $0.50  $0.85 

1.2For the three months ended December 30, 2023 and December 31, 2022, 2.4 million and 2.65.8 million shares, respectively, were excluded from the diluted EPS calculation for the quarterly and two quarterly periods ended April 1, 2023 as their effect would be anti-dilutive.  1.2 million and 1.3 million shares were excluded for the quarterly and two quarterly periods ended April 2, 2022. 

13

13.11.  Accumulated Other Comprehensive Loss

The components and activity of Accumulated other comprehensive loss are as follows:

Quarterly Period Ended 
Currency
Translation
  
Defined Benefit
Pension and Retiree
Health Benefit Plans
  
Derivative
Instruments
  
Accumulated Other
Comprehensive Loss
 
Balance at December 31, 2022 $(314) $(32) $83  $(263)
Other comprehensive income (loss) before reclassifications  60      (21)  39 
Net amount reclassified        (10)  (10)
Balance at April 1, 2023 $(254) $(32) $52  $(234)
Quarterly Period Ended 
Currency
Translation
  
Defined Benefit
Pension and Retiree
Health Benefit Plans
  
Derivative
Instruments
  
Accumulated Other
Comprehensive Loss
 
Balance at September 30, 2023 $(340) $(84) $88  $(336)
Other comprehensive income before reclassifications  139      (65)  74 
Net amount reclassified from accumulated other comprehensive loss        (12)  (12)
Balance at December 30, 2023 $(201) $(84) $11  $(274)

  
Currency
Translation
  
Defined Benefit
Pension and Retiree
Health Benefit Plans
  
Derivative
Instruments
  
Accumulated Other
Comprehensive Loss
 
Balance at January 1, 2022 $(176) $(67) $(46) $(289)
Other comprehensive income (loss) before reclassifications  37      69   106 
Net amount reclassified        2   2 
Balance at April 2, 2022 $(139) $(67) $25  $(181)
  
Currency
Translation
  
Defined Benefit
Pension and Retiree
Health Benefit Plans
  
Derivative
Instruments
  
Accumulated Other
Comprehensive Loss
 
Balance at October 1, 2022 $(455) $(32) $84  $(403)
Other comprehensive income before reclassifications  141      5   146 
Net amount reclassified from accumulated other comprehensive loss        (6)  (6)
Balance at December 31, 2022 $(314) $(32) $83  $(263)

Two Quarterly Periods Ended 
Currency
Translation
  
Defined Benefit
Pension and Retiree
Health Benefit Plans
  
Derivative
Instruments
  
Accumulated Other
Comprehensive Loss
 
Balance at October 1, 2022 $(455) $(32) $84  $(403)
Other comprehensive income (loss) before reclassifications  201      (16)  185 
Net amount reclassified        (16)  (16)
Balance at April 1, 2023 $(254) $(32) $52  $(234)
12.  Subsequent Events

  
Currency
Translation
  
Defined Benefit
Pension and Retiree
Health Benefit Plans
  
Derivative
Instruments
  
Accumulated Other
Comprehensive Loss
 
Balance at October 2, 2021 $(154) $(67) $(75) $(296)
Other comprehensive income (loss) before reclassifications  15      95   110 
Net amount reclassified        5   5 
Balance at April 2, 2022 $(139) $(67) $25  $(181)
During January 2024, the Company issued $800 million aggregate principal amount of 5.650% first priority senior secured notes due 2034.  The proceeds were used to prepay the 0.95% First Priority Senior Secured Notes due in February 2024 and a portion of the existing term loan due in July 2026.  As a result of the transaction, the Company also terminated its $500 million interest rate swap due in June 2026 for proceeds of $4 million.

In February 2024, the Company announced plans for a spin-off and merger of its Health, Hygiene & Specialties segment (excluding Tapes) with Glatfelter Corporation (“GLT”).  Upon the completion of the transaction, shareholders of Berry will own approximately ninety percent of the new combined company in addition to their continuing interest in Berry.  The transaction is expected to be tax-free to Berry and its shareholders.  The transaction is subject to certain customary closing conditions including, but not limited to, approval by GLT shareholders, the effective filing of related registration statements, completion of a tax-free spin-off and receipt of certain required foreign anti-trust approvals.

1413

Index

Item 2.Management’s Discussion and Analysis of Financial Condition and Results of Operations

Executive Summary

Business.  The Company’s operations are organized into four operating segments: Consumer Packaging International, Consumer Packaging North America, Health, Hygiene & Specialties, and Flexibles, formerly known as Engineered Materials.  The structure is designed to align us with our customers, provide improvedoptimal service, drive future growth, and to facilitate synergiessynergy realization.  The Consumer Packaging International segment primarily consists of closures and dispensing systems, pharmaceutical devices and packaging, bottles and canisters, containers, and containers.technical components.  The Consumer Packaging North America segment primarily consists of containers and pails, foodservice, closures, bottles and prescription vials, and tubes.  The Health, Hygiene & Specialties segment, which is being evaluated for strategic alternatives, primarily consists of healthcare, hygiene, specialties, and tapes.  The Engineered MaterialsFlexibles segment primarily consists of stretch and shrink films, converter films, institutional can liners, food and consumer films, retail bags, and agriculture films.

Raw Material Trends.  Our primary raw material is polymer resin.  In addition, we use other materials such as colorants, linerboard,butyl rubber, adhesives, paper and packaging materials, linerboard, rayon, polyester fiber, and foil, in various manufacturing processes.  While temporary industry-wide shortages of raw materials have occurred, we have historically been able to manage the supply chain disruption by working closely with our suppliers and customers.  Changes in the price of raw materials are generally passed on to customers through contractual price mechanisms over time, during contract renewals and other means.

Outlook.  The Company is affected by general economic and industrial growth, raw material availability, cost inflation, supply chain disruptions, and general industrial production.consumption levels.  Our business has both geographic and end market diversity, which reduces the effect of any one of these factors on our overall performance.  Our results are affected by our ability to pass through raw material and other cost changes to our customers, improve manufacturing productivity, and adapt to volume changes of our customers.  Despite global macro-economic challenges in the short-term attributed to continued rising inflation and general market softness, and continued inflation, particularly in Europe, we continue to believe our underlying long-term demand fundamentalfundamentals in all divisions will remain strong as we focus on delivering protective solutions that enhance consumer safety and by providing advantaged products in targeted markets.strong.  For fiscal 2023,2024, we project cash flow from operations between $1.4$1.35 to $1.5$1.45 billion and free cash flow between $800 to $900 million.  Projected fiscal 20232024 free cash flow assumes $600$550 million of capital spending.  For the calculationdefinition of free cash flow and further information related to free cash flow as a non-GAAP financial measure, see “Liquidity and Capital Resources.”

Results of Operations

Comparison of the Quarterly Period Ended April 1,December 30, 2023 (the “Quarter”) and the Quarterly Period Ended April 2,December 31, 2022 (the “Prior Quarter”)

Business integration expenses consist of restructuring and impairment charges, divestiture related costs, and other business optimization costs.  Tables present dollars in millions.

Consolidated Overview                  
 Quarter  Prior Quarter  $ Change  % Change  Quarter  Prior Quarter  $ Change  % Change 
Net sales $3,288  $3,775  $(487)  (13)% $2,853  $3,060  $(207)  (7)%
Cost of goods sold  2,682   3,154   (472)  (15)%  2,379   2,542   (163)  (6)%
Other operating expenses  305   280   25   9%  317   308   9   3%
Operating income $301  $341  $(40)  (12)% $157  $210  $(53)  (25)%

Net Sales:  sales:The net sales decline is primarily attributed to a 6% volume decline, decreased selling prices of $143$189 million due to the pass-throughpass through of lower resinpolymer costs an $80and a 3% volume decline from continued general market softness, partially offset by a $64 million unfavorablefavorable impact from foreign currency changes, and Prior Quarter divestiture sales of $42 million.  The volume decline is primarily attributed to general market softness and ongoing inventory destocking.changes.

Cost of goods sold:  The cost of goods sold decrease is primarily attributed to lower raw material prices,costs and the volume decline, partially offset by foreign currency changes, and Prior Quarter divestiture cost of goods sold.changes.

Other operating expenses:  The other operating expenses increase is primarily attributed to an increase in business integration costs and selling, general, and administrative expenses.costs.

Operating Income:income:  The operating income decrease is primarily attributed to a $35$20 million unfavorable impact from price cost spread related to the timing of passing through resin costs, a $16 million unfavorable impact from the volume decline, an $18a $15 million increase in business integration costs,depreciation and amortization expense, a $15 million unfavorable impact from foreign currency changes,hyperinflation in our Argentinian subsidiary and an unfavorable impact from increased selling, general, and administrative expenses.business integration costs.  These declines arewere partially offset by acquisition operating income and a $40$10 million favorable impact from price cost spread as a result of cost reduction and improved product mix.foreign currency changes.
1514

Index

Consumer Packaging International                  
 Quarter  Prior Quarter  $ Change  % Change  Quarter  Prior Quarter  $ Change  % Change 
Net sales $1,059  $1,139  $(80)  (7)% $917  $936  $(19)  (2)%
Operating income $75  $97  $(22)  (23)% $31  $47  $(16)  (34)%

Net Sales:  sales:The net sales decline in the Consumer Packaging International segment is primarily attributed to decreased selling prices of $31 million and a $573% volume decline from general market softness, partially offset by a $40 million unfavorablefavorable impact from foreign currency changes, a 5% volume decline, and Prior Quarter divestiture sales of $42 million, partially offset by increased selling prices of $76 million due to the pass-through of European inflation.  The volume decline is primarily attributed to general market softness.changes.

Operating Income:income:  The operating income decrease is primarily attributed to an $11 million unfavorable impact from price cost spread, a $10$7 million unfavorableincrease in depreciation and amortization expense, and an unfavorable impact from the volume decline, partially offset by a $9 million unfavorablefavorable impact from foreign currency changes, a $7 million unfavorable impact from increased business integration costs, and increased selling, general, and administrative expenses. These items are partially offset by a $10 million favorable impact from price cost spread.changes.
 
Consumer Packaging North America
         
  Quarter  Prior Quarter  $ Change  % Change 
Net sales $774  $880  $(106)  (12)%
Operating income $93  $85  $8   9%

Consumer Packaging North America         
  Quarter  Prior Quarter  $ Change  % Change 
Net sales $699  $764  $(65)  (9)%
Operating income $63  $71  $(8)  (11)%

Net Sales:  sales:The net sales decline in the Consumer Packaging North America segment is primarily attributed to decreased selling prices of $80$45 million and a 3% volume decline. The4% volume decline is primarily attributed tofrom general market softness particularly in industrials, partially offset by growth in our foodservice market.acquisition sales of $11 million.

Operating Income:income:  The operating income increasedecrease is primarily attributed to a $24$6 million favorableunfavorable impact from price cost spread, partially offset by unfavorable impacts from the volume decline increased business integration costs, and increased selling, general,a $5 million increase in depreciation and administrative expenses.amortization expense, partially offset by acquisition operating income. 

Health, Hygiene & Specialties                  
 Quarter  Prior Quarter  $ Change  % Change  Quarter  Prior Quarter  $ Change  % Change 
Net sales $677  $822  $(145)  (18)% $603  $663  $(60)  (9)%
Operating income $34  $69  $(35)  (51)%
Operating income (loss) $(3) $34  $(37)  (109)%

Net Sales:  sales:The net sales decline in the Health, Hygiene & Specialties segment is primarily attributed to a 9% volume decline and decreased selling prices of $64 million.  Themillion and a 2% volume decline is primarily attributed to general marketfrom softness in our specialtieshygiene and specialty markets, and ongoing inventory destocking.partially offset by a $17 million favorable impact from foreign currency changes.

Operating Income:income (loss):  The operating income decrease is primarily attributed to a $19$15 million unfavorable impact from price cost spread, a $15 million unfavorable impact from hyperinflation in our Argentinian subsidiary, and a $9 million unfavorable impact fromincrease in business optimization expense related to both plant rationalizations and costs associated with the volume decline.formal process to evaluate strategic alternatives of the segment.

Engineered Materials         
Flexibles         
 Quarter  Prior Quarter  $ Change  % Change  Quarter  Prior Quarter  $ Change  % Change 
Net sales $778  $934  $(156)  (17)% $634  $697  $(63)  (9)%
Operating income $99  $90  $9   10% $66  $58  $8   14%

Net Sales:  sales:The net sales decline in the Engineered MaterialsFlexibles segment is primarily attributed to decreased selling prices of $75$49 million and a 7%3% volume decline andin our industrial markets partially offset by growth in our premium protection film products in North America, partially offset by a $16 million unfavorablefavorable impact from foreign currency changes.The volume decline is primarily attributed to general market softness in European industrial markets and ongoing inventory destocking.

Operating Income:income:  The operating income increase is primarily attributed to a $25an $8 million favorable impact from price cost spread, partially offset by an $11 million unfavorable impact from the volume decline.spread.

Interest expense         
  Quarter  Prior Quarter  $ Change  % Change 
Interest expense $79  $71  $8   11%
Other expense         
  Quarter  Prior Quarter  $ Change  % Change 
Other expense $12  $1  $11   1,100%

The interestother expense increase is primarily attributed to higher debt extinguishment and foreign currency changes related to the resultremeasurement of higher interest rates.non-operating intercompany balances in the Quarter.

1615

Index

Changes in Comprehensive Income

The $110$125 million decline in comprehensiveComprehensive income from the Prior Quarter is primarily attributed to a $102$76 million unfavorable change in the fair value of derivative instruments, net of tax, and a $31$47 million decline in net income, partially offset by a $23 million favorable change in currency translation.Net income.  Currency translation changes are primarily related to non-U.S. subsidiaries with a functional currency other than the U.S. dollarDollar whereby assets and liabilities are translated from the respective functional currency into U.S. dollarsDollars using period-end exchange rates.  The change in currency translation in the Quarter was primarily attributed to locations utilizing the Euro and British pound sterling as their functional currency.  As part of the overall risk management, the Company uses derivative instruments to (i) reduce our exposure to changes in interest rates attributed to the Company’s floating-rate borrowings and (ii) reduce foreign currency exposure to translation of certain foreign operations.  The Company records changes to the fair value of these instruments in Accumulated other comprehensive loss.  The change in fair value of these instruments in fiscal 20232024 versus fiscal 20222023 is primarily attributed to thea change in the forward interest and foreign exchange curves between measurement dates.

Comparison of the Two Quarterly Periods Ended April 1, 2023 (the “YTD”) and the Two Quarterly Periods Ended April 2, 2022 (the “Prior YTD”)

Business integration expenses consist of restructuring and impairment charges, divestiture related costs, and other business optimization costs.  Tables present dollars in millions.

Consolidated Overview         
  YTD  Prior YTD  $ Change  % Change 
Net sales $6,348  $7,348  $(1,000)  (14)%
Cost of goods sold  5,224   6,192   (968)  (16)%
Other operating expenses  613   586   27   5%
Operating income $511  $570  $(59)  (10)%

Net Sales:  The net sales decline is primarily attributed to a 6% volume decline, decreased selling prices of $286 million due to the pass-through of lower resin costs, a $188 million unfavorable impact from foreign currency changes, and Prior YTD divestiture sales of $81 million.  The volume decline is primarily attributed to general market softness and customer destocking as supply chains normalize.

Cost of goods sold:  The cost of goods sold decrease is primarily attributed to lower raw material prices, the volume decline, foreign currency changes, and Prior YTD divestiture cost of goods sold.

Other operating expenses:  The other operating expenses increase is primarily attributed to an increase in business integration costs.

Operating Income:  The operating income decrease is primarily attributed to a $68 million unfavorable impact from the volume decline, a $37 million unfavorable impact from foreign currency changes, and a $26 million unfavorable impact from increased business integration costs.  These declines are partially offset by a $90 million favorable impact from price cost spread as a result of cost reduction and improved product mix.
 
Consumer Packaging International
         
  YTD  Prior YTD  $ Change  % Change 
Net sales $1,995  $2,195  $(200)  (9)%
Operating income $121  $166  $(45)  (27)%

Net Sales:  The net sales decline in the Consumer Packaging International segment is primarily attributed to a $122 million unfavorable impact from foreign currency changes, a 5% volume decline, and Prior Quarter divestiture sales of $81 million, partially offset by increased selling prices of $116 million due to the pass-through of European inflation.  The volume decline is primarily attributed to general market softness.

Operating Income:  The operating income decrease is primarily attributed to a $25 million unfavorable impact from foreign currency changes, a $20 million unfavorable impact from the volume decline, and an $8 million unfavorable impact from increased business integration costs. These declines are partially offset by a $16 million favorable impact from price cost spread.
17


Consumer Packaging North America         
  YTD  Prior YTD  $ Change  % Change 
Net sales $1,537  $1,732  $(195)  (11)%
Operating income $164  $131  $33   25%

Net Sales:  The net sales decline in the Consumer Packaging North America segment is primarily attributed to decreased selling prices of $142 million and a 3% volume decline. The volume decline is primarily attributed to general market softness partially offset by growth in our foodservice market.

Operating Income:  The operating income increase is primarily attributed to a $58 million favorable impact from price cost spread, partially offset by a $9 million unfavorable impact from the volume decline and an unfavorable impact from increased selling, general, and administrative expenses.

Health, Hygiene & Specialties         
  YTD  Prior YTD  $ Change  % Change 
Net sales $1,340  $1,640  $(300)  (18)%
Operating income $68  $131  $(63)  (48)%

Net Sales:  The net sales decline in the Health, Hygiene & Specialties segment is primarily attributed to a 9% volume decline, decreased selling prices of $136 million, and a $25 million unfavorable impact from foreign currency changes.  The volume decline is primarily attributed to general market softness and customer destocking as supply chains normalize.

Operating Income:  The operating income decrease is primarily attributed to a $38 million unfavorable impact from price cost spread, a $17 million unfavorable impact from the volume decline, and an $8 million unfavorable impact from foreign currency changes.

Engineered Materials         
  YTD  Prior YTD  $ Change  % Change 
Net sales $1,476  $1,781  $(305)  (17)%
Operating income $158  $142  $16   11%

Net Sales:  The net sales decline in the Engineered Materials segment is primarily attributed to an 8% volume decline, decreased selling prices of $124 million, and a $41 million unfavorable impact from foreign currency changes.  The volume decline is primarily attributed to general market softness and customer destocking as supply chains normalize.

Operating Income:  The operating income increase is primarily attributed to a $54 million favorable impact from price cost spread, partially offset by a $22 million unfavorable impact from the volume decline, an unfavorable impact from increased selling, general, and administrative expenses, and an unfavorable impact from increased business integration costs.

Interest expense         
  YTD  Prior YTD  $ Change  % Change 
Interest expense $150  $142  $8   6%

The interest expense increase is primarily the result of higher interest rates.

Changes in Comprehensive Income

The $8 million improvement in comprehensive income from the Prior YTD was primarily attributed to a $186 million favorable change in currency translation, partially offset by a $132 million unfavorable change in the fair value of derivative instruments, net of tax, and a $46 million decline in net income.  Currency translation changes are primarily related to non-U.S. subsidiaries with a functional currency other than the U.S. dollar whereby assets and liabilities are translated from the respective functional currency into U.S. dollars using period-end exchange rates.  The change in currency translation in the YTD was primarily attributed to locations utilizing the Euro and British pound sterling as their functional currency.  As part of the overall risk management, the Company uses derivative instruments to (i) reduce our exposure to changes in interest rates attributed to the Company’s borrowings and (ii) reduce foreign currency exposure to translation of certain foreign operations.  The Company records changes to the fair value of these instruments in Accumulated other comprehensive loss.  The change in fair value of these instruments in fiscal 2023 versus fiscal 2022 is primarily attributed to the change in the forward interest and foreign exchange curves between measurement dates.
18


Liquidity and Capital Resources

Senior Secured Credit Facility

We manage our global cash requirements considering (i) available funds among the many subsidiaries through which we conduct business, (ii) the geographic location of our liquidity needs, and (iii) the cost to access international cash balances.  At the end of the Quarter, the Company had no outstanding balance on its $1,050 million$1.0 billion asset-based revolving line of credit that matures in May 2024.June 2028.  The Company was in compliance with all covenants at the end of the Quarter.

Cash Flows

Net cash from operating activities increased $182$34 million from the Prior YTDQuarter primarily attributed to working capital improvement.improvement and the settlement of derivatives in the Quarter, partially offset by a decline in net income prior to non-cash activities.

Net cash used in investing activities increased $109decreased $28 million from the Prior YTDQuarter primarily attributed to the acquisition of Pro-Westerndecreased investments in  the YTD.property, plant and equipment.

Net cash used in financing activities increased $358$64 million from the Prior YTDQuarter primarily attributed to higher net repayments ofon long-term debt, and initiation of a quarterly dividend in the YTD.partially offset by lower share repurchases.

Dividend Payments

TheDuring the quarter, the Company declared and paid a cash dividenddividends of $0.25 per share during both the first fiscal quarter that ended December 31, 2022 and the second fiscal quarter that ended April 1, 2023.$36 million.

Share Repurchases

YTD fiscal 2023,During the quarter, the Company repurchased approximately 6 million106 thousand shares for $333$7 million.  Authorized share repurchases of $710The Company has $435 million remain available to the Company.remaining under its repurchase plan.

Free Cash Flow

Our consolidated free cash flow for the YTDQuarter and Prior YTDQuarter are summarized as follows:

 April 1, 2023  April 2, 2022  December 30, 2023  December 31, 2022 
Cash flow from operating activities $168  $(14) $(199) $(233)
Additions to property, plant and equipment, net  (385)  (367)  (183)  (211)
Free cash flow $(217) $(381) $(382) $(444)

We use free cash flow as a supplemental measure of liquidity as it assists us in assessing our ability to fund growth through generation of cash.  Free cash flow may be calculated differently by other companies, including other companies in our industry or peer group, limiting its usefulness on a comparative basis.  Free cash flow is not a financial measure presented in accordance with generally accepted accounting principles ("GAAP") and should not be considered as an alternative to any other measure determined in accordance with GAAP.

16



Liquidity Outlook

At April 1,December 30, 2023, our cash balance was $696$507 million, which was primarily located outside the U.S.  We believe our existing and future U.S. based cash and cash flow from U.S. operations, together with available borrowings under our senior secured credit facilities, will be adequate to meet our short-term and long-term liquidity needs with the exception of funds needed to cover all long-term debt obligations, which we intend to refinance prior to maturity.  The Company has the ability to repatriate the cash located outside the U.S. to the extent not needed to meet operational and capital needs without significant restrictions.
19


Summarized Guarantor Financial Information

Berry Global, Inc. (“Issuer”) has notes outstanding which are fully, jointly, severally, and unconditionally guaranteed by its parent, Berry Global Group, Inc. (for purposes of this section, “Parent”) and substantially all of Issuer’s domestic subsidiaries. Separate narrative information or financial statements of the guarantor subsidiaries have not been included because they are 100% owned by Parent and the guarantor subsidiaries unconditionally guarantee such debt on a joint and several basis. A guarantee of a guarantor subsidiary of the securities will terminate upon the following customary circumstances: the sale of the capital stock of such guarantor if such sale complies with the indentures, the designation of such guarantor as an unrestricted subsidiary, the defeasance or discharge of the indenture or in the case of a restricted subsidiary that is required to guarantee after the relevant issuance date, if such guarantor no longer guarantees certain other indebtedness of Issuer. The guarantees of the guarantor subsidiaries are also limited as necessary to prevent them from constituting a fraudulent conveyance under applicable law and any guarantees guaranteeing subordinated debt are subordinated to certain other of the Company’s debts. Parent also guarantees Issuer’s term loans and revolving credit facilities. The guarantor subsidiaries guarantee our term loans and are co-borrowers under our revolving credit facility.

Presented below is summarized financial information for the Parent, Issuer and guarantor subsidiaries on a combined basis, after intercompany transactions have been eliminated.

 Two Quarterly Periods Ended  Quarterly Period Ended 
 April 1, 2023  December 30, 2023 
Net sales $3,346  $1,506 
Gross profit  653   297 
Earnings from continuing operations  231   67 
Net income $231  $67 

Includes $4$5 million of incomeexpense associated with intercompany activity with non-guarantor subsidiaries.

 April 1, 2023  October 1, 2022  December 30, 2023  September 30, 2023 
Assets            
Current assets $1,618  $2,432  $1,443  $1,975 
Noncurrent assets  5,961   6,137   5,944   5,997 
                
Liabilities                
Current liabilities $915  $1,536  $1,231  $1,363 
Intercompany payable  636   634 
Noncurrent liabilities  10,676   10,630   10,035   10,271 

20

Includes $754 million of intercompany payables due to non-guarantor subsidiaries as of December 30, 2023 and September 30, 2023, respectively.

Item 3.  Quantitative and Qualitative Disclosures about Market Risk

Interest Rate Risk

We are exposed to market risk from changes in interest rates primarily through our senior secured credit facilities.facilities and accounts receivable supply chain finance factoring programs.  Our senior secured credit facilities are comprised of (i) $3.4$2.8 billion term loans and (ii) a $1,050 million$1.0 billion revolving credit facility with no balanceborrowings outstanding.  Borrowings under our senior secured credit facilities bear interest at a rate equal to an applicable margin plus LIBOR or SOFR.  The applicable margin for SOFR rate borrowings under the revolving credit facility ranges from 1.25% to 1.50%, and the margin for the term loans is 1.75% per annum.  As of period end, the LIBORSOFR rate of approximately 4.86%5.38% was applicable to the term loans.  For the portionA change of our term loans that are not hedged by0.25% on these floating interest rate swaps, a 0.25% change in LIBORexposures would increase our annual interest expense by $2 million on variable rate term loans.approximately $1 million.
17



We seek to minimize interest rate volatility risk through regular operating and financing activities and, when deemed appropriate, through the use of derivative financial instruments.  These financial instruments are not used for trading or other speculative purposes. (See Note 8.6.)

Foreign Currency Risk

As a global company, we face foreign currency risk exposure from fluctuating currency exchange rates, primarily the U.S. dollar against the euro, British pound sterling, Brazilian real, Chinese renminbi, Canadian dollar and Mexican peso.  Significant fluctuations in currency rates can have a substantial impact, either positive or negative, on our revenue, cost of sales, and operating expenses.   Currency translation gains and losses are primarily related to non-U.S. subsidiaries with a functional currency other than U.S. dollars whereby assets and liabilities are translated from the respective functional currency into U.S. dollars using period-end exchange rates and impact our Comprehensive income.  A 10% decline in foreign currency exchange rates would have had a $12an $4 million unfavorable impact on our Net income for the two quarterly periodsperiod ended April 1,December 30, 2023. (See Note 8.6.)

Item 4.  Controls and Procedures

(a) Evaluation of disclosure controls and procedures.

Under applicable Securities and Exchange Commission regulations, management of a reporting company, with the participation of the principal executive officer and principal financial officer, must periodically evaluate the company’s “disclosure controls and procedures,” which are defined generally as controls and other procedures of a reporting company designed to ensure that information required to be disclosed by the reporting company in its periodic reports filed with the commission (such as this Form 10-Q) is recorded, processed, summarized, and reported on a timely basis.

The Company’s management, with the participation of the Chief Executive Officer and the Chief Financial Officer, carried out an evaluation of the effectiveness of the design and operation of the disclosure controls and procedures as of the end of the period covered by this report.  Based on this evaluation, our Chief Executive Officer and Chief Financial Officer concluded that the design and operation of our disclosure controls and procedures were effective at the reasonable assurance level as of the end of the period covered by this report.

(b) Changes in internal control over financial reporting.

There were no changes in our internal control over financial reporting that occurred during the Quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

2118

Index

Part II.  Other Information

Item 1.  Legal Proceedings

There have been no material changes in legal proceedings from the items disclosed in our most recent Form 10-K filed with the Securities and Exchange Commission.

Item 1A.  Risk Factors

Before investing in our securities, we recommend that investors carefully consider the risks described in our most recent Form 10-K and subsequent periodic reports filed with the Securities and Exchange Commission, including those under the heading “Risk Factors” and other information contained in this Quarterly Report.  Realization of any of these risks could have a material adverse effect on our business, financial condition, cash flows and results of operations.

Additionally, we caution readers that the list of risk factors discussed in our most recent Form 10-K and subsequent periodic reports may not contain all of the material factors that are important to you.  In addition, in light of these risks and uncertainties, the matters referred to in the forward-looking statements contained in this report may not in fact occur.  Accordingly, readers should not place undue reliance on those statements.

Item 2.  Unregistered Sales of Equity Securities and Use of Proceeds

Issuer Repurchases of Equity Securities

The following table summarizes the Company's repurchases of its common stock during the Quarterly Period ended April 1,December 30, 2023.

Fiscal Period 
Total Number of
Shares Purchased
  
Average Price
Paid Per Share
  
Total Number of Shares
Purchased as Part of Publicly
Announced Programs
  
Dollar Value of Shares that
May Yet be Purchased Under
the Program (in millions) (a)
 
January  80,000  $64.50   80,000  $859 
February  1,519,597   62.50   1,519,597   764 
March  944,808   58.06   944,808   710 
  Total  2,544,405  $60.92   2,544,405  $710 
Fiscal Period 
Total Number of
Shares Purchased
  
Average Price
Paid Per Share
  
Total Number of Shares
Purchased as Part of Publicly
Announced Programs
  
Dollar Value of Shares that
May Yet be Purchased Under
the Program (in millions) (a)
 
October    $     $442 
November  69,755   64.48   69,755   437 
December  35,934   65.40   35,934   435 
  Total  105,689  $64.79   105,689  $435 

(a)All open market purchases during the quarter were made under the 2023 authorization from our board of directors.

2219

Index

Item 5.  Other Information

Rule 10b5-1 Plan Elections

No officers or directors, as defined in Rule 16a-1(f), adopted, modified and/or terminated a "Rule 10b5-1 trading arrangement" or a "non-Rule 10b5-1 trading arrangement," as defined in Regulation S-K Item 408, during the first quarter of fiscal 2024.

Item 6.  Exhibits

Exhibit No. Description of Exhibit
Indenture, among Berry Global, Inc., certain guarantors party thereto, U.S. Bank Trust Company, National Association, as Trustee and Collateral Agent, relating to the 5.50% First Priority Senior Secured Notes due 2028, dated March 30, 2023 (incorporated by reference to Exhibit 4.1 to the Company’s Current Report on Form 8-K filed on March 30, 2023).
Registration Rights Agreement, by and between Berry Global, Inc., Berry Global Group, Inc., each subsidiary of Berry Global, Inc. identified therein, and Citigroup Global Markets Inc., J.P. Morgan Securities LLC and Wells Fargo Securities, LLC, on behalf of themselves and as representatives of the initial purchasers, relating to the 5.50% First Priority Senior Secured Notes due 2028 (incorporated by reference to Exhibit 4.2 to the Company’s Current Report on Form 8-K filed on March 30, 2023).
 Subsidiary Guarantors.
 Rule 13a-14(a)/15d-14(a) Certification of the Chief Executive Officer.
 Rule 13a-14(a)/15d-14(a) Certification of the Chief Financial Officer.
 Section 1350 Certification of the Chief Executive Officer.
 Section 1350 Certification of the Chief Financial Officer.
101.INS Inline XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document).
101.SCH Inline XBRL Taxonomy Extension Schema Document.
101.CAL Inline XBRL Taxonomy Extension Calculation Linkbase Document.
101.DEF Inline XBRL Taxonomy Extension Definition Linkbase Document.
101.LAB Inline XBRL Taxonomy Extension Label Linkbase Document.
101.PRE Inline XBRL Taxonomy Extension Presentation Linkbase Document.
104 Cover Page Interactive Date File (formatted as Inline XBRL and contained in Exhibit 101).

*Filed herewith
**Furnished herewith


2320

Index

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 Berry Global Group, Inc. 
    
May 4, 2023February 7, 2024By:/s/ Mark W. Miles 
  Mark W. Miles 
  Chief Financial Officer 

24

21